This compound is a triazole derivative featuring a hydroxymethyl substituent. It is primarily utilized as an intermediate in the synthesis of other chemical entities.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 135242-93-2
Fmoc-L-cysteine
pharmaceutical intermediate
3-Bromo-6-chloroimidazo[1,2-b]pyridazine
pharmaceutical intermediate
1-(Dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-2-propanol hydrochloride
pharmaceutical intermediate
2β,16β-bis(piperidin-1-yl)-5α-androstane-3α,17β-diyl diacetate
pharmaceutical intermediate
(1-methyl-1H-1,2,4-triazol-3-yl)methanamine hydrochloride
pharmaceutical intermediate
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride
pharmaceutical intermediate
Guanazole
research compound
1-(1H-1,2,4-triazol-1-yl)ethan-1-one
pharmaceutical intermediate
(1-methyl-1,2,4-triazol-3-yl)methanol
WEDYTSQNYJKOPC-UHFFFAOYSA-N
CN1C=NC(=N1)CO
—